Prognostic value of baseline absolute lymphocyte concentration and neutrophil/lymphocyte ratio in dogs with newly diagnosed multi-centric lymphoma
Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation
Determination of MDR1 gene expression for prediction of chemotherapy tolerance and treatment outcome in dogs with lymphoma
Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease
Three-dimensional conformal radiation therapy alone or in combination with surgery for treatment of canine intracranial meningiomas
Mechlorethamine, vincristine, melphalan and prednisone (MOMP) for the treatment of relapsed lymphoma in dogs
Frameless stereotactic radiosurgery for the treatment of primary intracranial tumours in dogs *
Effects of low-dose cyclophosphamide with piroxicam on tumour neovascularization in a canine oral malignant melanoma-xenografted mouse model
Detection of comorbidities and synchronous primary tumours via thoracic radiography and abdominal ultrasonography and their influence on treatment outcome in dogs with soft tissue sarcomas, primary brain tumours and intranasal tumours *
Vinorelbine rescue therapy for dogs with primary urinary bladder carcinoma
1,25-Dihydroxyvitamin D3 and its analogues increase catalase at the mRNA, protein and activity level in a canine transitional carcinoma cell line
Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours
Flow cytometric evaluation of ki67 for the determination of malignancy grade in canine lymphoma
Quantitative morphology in canine cutaneous soft tissue sarcomas
Selection of suitable reference genes for normalization of genes of interest in canine soft tissue sarcomas using quantitative real-time polymerase chain reaction
The European canine lymphoma network: a joining initiative to generate consensus guidelines for the diagnosis and therapy in canine lymphoma and research partnership